Table 2: Lung cancer incidence (%) by sex, age and histological type, Granada 2011–2012.
|
|
Men |
Women |
||
|
Age |
||||
|
15-44 |
10 (1.7%) |
6 (5.3%) |
||
|
45-54 |
46 (8.1%) |
34(30.1%) |
||
|
55-64 |
118 (20.6%) |
27 (23.9%) |
||
|
65-74 |
187(32.7%) |
15 (13.3%) |
||
|
≥ 75 |
211 (36.9%) |
31 (27.4%) |
||
|
Histologic type |
||||
|
Non-microscopic verification |
114 (19.9%) |
17 (15.2%) |
||
|
Microscopic verification |
459 (80.1%) |
95 (84.8%) |
||
|
ADC |
156 (35%) |
63 (68.5%) |
||
|
SCC |
165 (37%) |
9 (9.8%) |
||
|
LCC |
13 (2.9%) |
1 (1.1%) |
||
|
SCLC |
88 (19.7%) |
14 (15.2%) |
||
|
Others |
24 (5.4%) |
5 (5.4%) |
||
|
Total |
446 (100%) |
92 (100%) |
||
|
NOS |
13 (2.3%) |
3 (2.7%) |
||
ADC adenocarcinoma, SCC squamous cell carcinoma, LCC large cell
carcinoma, SCLC small cell lung carcinoma, NOS not otherwise specified